
Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a member is changing plans or managing a new health condition, the experience should feel guided rather than overwhelming.
FDA has warned patients of TTP, a serious blood disorder that results from misuse of Opana ER.







